Nurse-Led Dialysis Self-Management Program for Hemodialysis Distress
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKutahya Health Sciences University
About this trial
Hemodialysis patients may experience dialysis-related distress due to long-term treatment requirements, dietary and fluid restrictions, medication use, vascular access problems, dialysis-related symptoms, and psychosocial challenges. Nurse-led self-management programs may help patients improve dialysis self-management, reduce distress, and support treatment adherence.
This study aims to evaluate the effect of a nurse-led needs-based dialysis self-management program on dialysis-related distress in patients receiving hemodialysis. The study will be conducted as a single-center, two-arm, parallel-group, randomized controlled trial. A total of 100 adult hemodialysis patients will be randomly assigned to either the intervention group or the control group in a 1:1 ratio.
Participants in the intervention group will receive a 6-week nurse-led needs-based dialysis self-management program in addition to routine hemodialysis care. Participants in the control group will continue routine hemodialysis care. Data will be collected at baseline, 6 weeks, and 18 weeks. The primary outcome is dialysis-related distress. Secondary outcomes include illness and treatment uncertainty, treatment adherence, and clinical adherence indicators.
Eligibility criteria
Qualifiers
Aged 18 years or older
Receiving hemodialysis treatment for at least 3 months
Receiving hemodialysis treatment at least twice per week
Able to read and understand Turkish
Disqualifiers
Advanced cognitive impairment
Active psychiatric crisis
History of major surgery or acute severe illness within the last 3 months
Planned kidney transplantation in the near future
Trial design
Treatments tested in this trial
- Nurse-Led Needs-Based Dialysis Self-Management Program
- Routine Hemodialysis Care
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov